Target Name: MIR15A
NCBI ID: G406948
Review Report on MIR15A Target / Biomarker Content of Review Report on MIR15A Target / Biomarker
MIR15A
Other Name(s): hsa-miR-15a-5p | hsa-miR-15a-3p | MicroRNA 15a | miRNA15A | MIRN15A | mir-15a | microRNA 15a | hsa-mir-15a

MIR15A: A promising drug target and biomarker for cancer

MIR15A, a microRNA (miRNA), has been identified as a promising drug target and biomarker for cancer. It is a non-coding RNA molecule that plays a crucial role in regulating gene expression, and its levels have been shown to be aberrant in various types of cancer. The study of MIR15A has significant implications for the development of new cancer therapies and treatments.

MIR15A is a promising drug target because it has been shown to be involved in the regulation of cell growth, apoptosis (programmed cell death), and angiogenesis (the formation of new blood vessels). It is a known regulator of the TGF-β pathway, which is a critical factor in cancer development. MIR15A has been shown to inhibit the activity of the TGF-β receptor, which is a key regulator of cell growth and differentiation.

In addition, MIR15A has also been shown to play a role in the regulation of apoptosis. Cancer cells often undergo apoptosis, which is a natural and necessary process for the growth and development of tissues. However, cancer cells can often evade apoptosis and continue to divide and proliferate. MIR15A has been shown to regulate the expression of genes that are involved in the production of factors that can inhibit apoptosis.

MIR15A has also been shown to be involved in the regulation of angiogenesis. Angiogenesis is the process by which new blood vessels are formed to supply oxygen and nutrients to the developing body. Cancer cells often use angiogenesis to their advantage, but MIR15A has been shown to regulate the production of new blood vessels.

The study of MIR15A has significant implications for the development of new cancer therapies and treatments. By targeting MIR15A with drugs, researchers hope to inhibit its activity and disrupt its role in cancer development. This could lead to the development of new treatments for a variety of cancer types, including breast, ovarian, and colorectal cancers.

In addition to its potential as a drug target, MIR15A has also been shown to be a potential biomarker for cancer. The levels of MIR15A have been shown to be aberrant in various types of cancer, and its levels have been used as a marker for the disease. This suggests that MIR15A could be a useful diagnostic tool for cancer researchers to study the progression of the disease and the effectiveness of different treatments.

Overall, the study of MIR15A has significant implications for the development of new cancer therapies and treatments. As further research is conducted, it is likely that the true potential of MIR15A will be revealed, and it will be exciting to see how its role in cancer development and treatment continues to evolve.

Protein Name: MicroRNA 15a

The "MIR15A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR15A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908 | MIR1909 | MIR190A | MIR190B | MIR191 | MIR1910 | MIR1911 | MIR1912 | MIR1913 | MIR1914 | MIR1915 | MIR1915HG | MIR192 | MIR193A | MIR193B | MIR193BHG | MIR194-1 | MIR194-2 | MIR194-2HG | MIR195 | MIR196A1 | MIR196A2 | MIR196B | MIR197 | MIR1972-1 | MIR1972-2 | MIR1973 | MIR1976 | MIR198 | MIR199A1 | MIR199A2 | MIR199B | MIR19A | MIR19B1 | MIR19B2 | MIR200A | MIR200B | MIR200C | MIR200CHG | MIR202 | MIR202HG | MIR203A | MIR203B | MIR204 | MIR205 | MIR2052 | MIR2052HG | MIR2053 | MIR2054 | MIR205HG | MIR206 | MIR208A | MIR208B | MIR20A | MIR20B | MIR21 | MIR210 | MIR210HG | MIR211 | MIR2110 | MIR2113 | MIR2114 | MIR2115 | MIR2116 | MIR2117 | MIR212 | MIR214 | MIR215 | MIR216A | MIR216B | MIR217 | MIR217HG | MIR218-1 | MIR218-2 | MIR219A1 | MIR219A2